QARZIBA dinutuximab beta 4.5 mg/mL concentrate for solution for infusion, 20 mg/4.5 mL vial ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

qarziba dinutuximab beta 4.5 mg/ml concentrate for solution for infusion, 20 mg/4.5 ml vial

recordati rare diseases australia pty ltd - dinutuximab beta, quantity: 4.5 mg/ml - solution - excipient ingredients: polysorbate 20; hydrochloric acid; sucrose; water for injections; histidine - qarziba is indicated for the treatment of high-risk neuroblastoma in patients who have previously received induction chemotherapy and achieved at least a partial response.

FEIBA 50units/ml (1,000unit) powder and 20ml solvent for solution for infusion vials यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

feiba 50units/ml (1,000unit) powder and 20ml solvent for solution for infusion vials

1,000unit) powder and 20ml solvent for solution for infusion vials (takeda uk ltd - factor viii inhibitor bypassing fraction - powder and solvent for solution for infusion - 1000unit

Albunorm 20% Solution for Infusion 200g/l माल्टा - अंग्रेज़ी - Medicines Authority

albunorm 20% solution for infusion 200g/l

octapharma (ip) limited - human albumin solution - solution for infusion - human albumin solution 200 g/l - blood substitutes and perfusion solutions